German Other Utilities Stock News

The US move to hit polysilicon imports with 15% tariffs and price floors has suddenly shifted the story for stocks tied into solar and semiconductor supply chains. Some companies now stand to gain from protected domestic production, while others face rising input costs and new trade risks. This article walks through three stocks exposed to these tariff catalysts, including one potential winner and two that may warrant extra caution. Enphase Energy (ENPH) Enphase Energy is a US based solar...

Earnings results put Carl Zeiss Meditec stock in focus Carl Zeiss Meditec (XTRA:AFX) has drawn fresh attention after reporting nine month earnings to June 30, 2026, with both sales and net income lower than the prior period, prompting investors to reassess the stock. See our latest analysis for Carl Zeiss Meditec. Following the earnings release on 5 August 2026, Carl Zeiss Meditec’s share price of €29.30 reflects pressure in the short term, with the stock down 3.2% over one day but still...

DEUTZ (XTRA:DEZ) has drawn fresh investor attention after reporting half year 2026 earnings on 6 August, with sales of €1,115.3m and net income of €32.9m from continuing operations. See our latest analysis for DEUTZ. The half year 2026 earnings update appears to have given DEUTZ fresh momentum, with the latest share price at €10.02 and a 30 day share price return of 9.09%, while the 1 year total shareholder return of 20.69% sits against a much larger 3 year total shareholder return of about...

Bayerische Motoren Werke stock has fallen 39.1% year to date, yet the broader valuation checks still point to shares looking cheap rather than fully priced. The share price is down 39.1% year to date, which raises the question of whether recent pessimism has pushed Bayerische Motoren Werke below what its fundamentals may justify. Planned cost savings from workforce reductions can support margins over time, while weaker profitability and softer demand in China remain a key risk for how...

Celebrations may be in order for Vonovia SE ( ETR:VNA ) shareholders, with the analysts delivering a significant...

Why Hensoldt Stock Is Back In Focus After Fresh Guidance Hensoldt (XTRA:HAG) has drawn renewed attention after confirming its 2026 earnings guidance and reporting higher first half 2026 sales, alongside a reduced net loss compared with the same period a year earlier. See our latest analysis for Hensoldt. These guidance and earnings updates have coincided with a clear pickup in Hensoldt’s share price momentum, with a 90 day share price return of 23.07% and a 5 year total shareholder return of...

It's been a good week for Springer Nature AG & Co. KGaA ( ETR:SPG ) shareholders, because the company has just released...

It's been a good week for Evonik Industries AG ( ETR:EVK ) shareholders, because the company has just released its...

The market for HELLA GmbH & Co. KGaA's ( ETR:HLE ) shares didn't move much after it posted weak earnings recently. We...

Last week, you might have seen that Fresenius Medical Care AG ( ETR:FME ) released its interim result to the market...

Infineon Technologies stock has delivered an 81.1% return over the past five years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings based multiples currently point to the shares trading at a premium rather than at a clear discount. Over 5 years, Infineon Technologies has returned 81.1%, which sets a high bar for any further upside to be justified by fundamentals. Record revenue supported by demand from AI data centres and automotive chips can support optimistic...

Deutsche Börse (XTRA:DB1) has drawn fresh attention after issuing earnings guidance for full year 2026, projecting €5.7b of net revenue and expecting total net revenue to exceed €6.4b. See our latest analysis for Deutsche Börse. The guidance update comes after a steady share price trend for Deutsche Börse, with a 90 day share price return of 11.0% and year to date share price return of 23.07%, while the 5 year total shareholder return of 100.40% points to a strong longer term record. If...

OHB shares went into this earnings print under pressure after a weak three month stretch, yet the real story today is the profit squeeze hiding behind solid top line momentum. Revenue for Q2 landed at €338.7m, but the company swung to a loss with basic earnings per share of €0.27 in the red. That clash between healthy sales in a capital intensive aerospace business and suddenly weaker profitability is what is driving the sentiment reset, as investors debate whether this is a blip or the start...

Why Wacker Chemie Stock Is Back On Investors’ Radar Wacker Chemie (XTRA:WCH) has drawn fresh attention after reporting half year 2026 earnings. Sales reached €2,923.2 million and the company moved from a prior net loss to net income of €351.2 million. See our latest analysis for Wacker Chemie. The latest half year earnings appear to have acted as a fresh catalyst for Wacker Chemie, with the stock recording a 7 day share price return of 11.52% and a year to date share price return of 34.15%...

Central banks are hinting at a gentler path as inflation pressures ease from earlier peaks. That kind of backdrop can reward leaders who think in decades and not quarters. Founder led companies often fit that profile because their wealth and reputation are tied directly to the business. This article highlights three stocks from the Founder Led Companies screener that show how that long term mindset can matter for a portfolio. The stocks covered below are just a small sample of founder led...

In early August 2026, Zalando SE reported second-quarter 2026 results showing sales rising to €3,424.4 million while net income fell to €73.8 million, alongside a net loss of €13.8 million for the first half despite higher six-month sales of €6,420.6 million. The company also refined its full-year 2026 outlook, guiding revenue growth toward the lower end of its prior 12%–17% range and highlighting that much of the strong reported expansion was driven by the About You acquisition rather than...

Sudden pressure on Caribbean citizenship by investment programs may sound distant from European travel and tourism stocks, yet it touches a powerful current in global mobility and high net worth travel. As visa rules tighten and wealthy travellers rethink where and how they move, capital and travel patterns can shift. This article explores three European travel stocks exposed to these trends, and why that mix of risk and potential might matter for your portfolio. The stocks covered in this...

What Deutsche Bank’s Q2 results and new buyback mean for shareholders Deutsche Bank (XTRA:DBK) has combined its second quarter 2026 earnings release with the launch of a €500 million share repurchase program, giving investors fresh information on profitability and capital returns. The bank reported second quarter net interest income of €4,549 million and net income of €1,850 million. Basic earnings per share from continuing operations was €0.58 and diluted earnings per share was €0.57. For...

Krones (XTRA:KRN) confirmed its 2026 earnings guidance and issued new revenue and dividend guidance through 2028, shortly after reporting largely stable second quarter 2026 sales and earnings compared with the prior year. See our latest analysis for Krones. Krones shares trade at €116.2, with the stock down 14.56% on a year to date share price basis, while the 5 year total shareholder return of 47.59% points to a stronger longer term record as recent momentum has softened. If Krones has you...

Siemens (XTRA:SIE) reports strong, profitable growth in its automation and software business, with CEO comments highlighting especially firm traction in China. The company points to competitive momentum in China as a key factor in recent business gains in industrial automation and digital tools. Siemens releases new insights on digital transformation and resilience of global energy infrastructure, underlining its role in ongoing energy transition efforts. Siemens is far from the only stock...

Redcare Pharmacy (XTRA:RDC) has drawn fresh attention after reporting half year 2026 results that combined higher sales with a wider net loss, while also confirming its full year revenue growth guidance. See our latest analysis for Redcare Pharmacy. Redcare Pharmacy’s recent half year update comes after a mixed share price pattern, with a 1 day share price return of 1.75% and a 90 day share price return of 38.85%, but a 1 year total shareholder return that declined 37.11%. This suggests short...

Vonovia went into this earnings release with a stock that has drifted, down about 6% over the past month and around 7% over three months, even as the P/E near 4.7x already priced in plenty of caution. The headline today is the profit story. Quarterly basic earnings per share came in at €0.87 on revenue of €1,605.5m, against a backdrop where the past 12 months have been shaped by a very large one off gain and a net profit margin of 63.9%. The market now has to decide whether that margin story...

The market has treated ElringKlinger like a balance sheet headache in recovery mode, yet the latest quarter tells a more nuanced story. The stock closed at €5.13 on 5 August, only slightly higher over the past month and still down over the last quarter. Against that backdrop, Q2 earnings showed solid revenue of €478.9m and net income of €11.2m, with management highlighting stronger operating free cash flow and a reinforced cash position. For investors, the real headline is that ElringKlinger...

The market had already pushed Fresenius SE KGaA up over the past quarter, with the stock closing at €46.65 on 5 August after a solid 90 day run. Today investors had to decide whether that optimism fits the new reality. The headline is clear. Fresenius delivered a health care earnings story built on profit quality, not hype, with core earnings per share for Q2 of €0.68 and group EBIT margin at 12.3%. The emotional pivot is this margin story. Traders focused on short term headlines risk missing...